Eurofarma Laboratórios S.A. Stock

Stocks

EUFA3

BREUFAACNOR4

Market Closed - Sao Paulo Other stock markets			5-day change	1st Jan Change
- ^BRL	-.--%		-.--%	-

05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

on all subscriptions*

Last hours

Enjoy this offer

* See conditions under "Our services"

Latest news : Eurofarma Laboratórios S.A.

05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
01-23	Bavarian Nordic A/S Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil	CI
12-10	Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investors	CI
11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-21	Mentis Care, Inc Appoints Hassan Kotob as Chief Executive Officer	CI
25-10-21	SK Biopharmaceuticals Co., Ltd. Launches Joint Venture with Eurofarma for Ai-Based Epilepsy Management Platform	CI
25-08-21	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-03-16	Eurofarma Laboratórios S.A. acquired 60% stake in Klibra Agenciamento de Marcas e Negócios for approximately BRL 160 million.	CI
24-11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-08-13	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI

More news

Managers and Directors: Eurofarma Laboratórios S.A.

Manager	Title	Age	Since
Marco Billi CEO	Chief Executive Officer	-	2021-11-22
Alexandre Mendes Palhares IRC	Investor Relations Contact	-	2021-11-22

Director	Title	Age	Since
Maurízio Billi CHM	Chairman	-	2021-11-22
Cristina Presz Palmaka de Luca BRD	Director/Board Member	57	2021-11-22
Juliana Rozenbaum Munemori BRD	Director/Board Member	49	2018-12-31

More insiders

Latest insider transactions

Date	Insider	Type	Quantity	% Market Cap.
25-01-09	Controlling Shareholder Brazilian	Buy	1,644,236	0.1665%
24-12-03	Controlling Shareholder Brazilian	Buy	15,405,639	1.5600%
24-12-03	Controlling Shareholder Brazilian	Sell	15,405,639	1.5600%

Transaction History

Financials

	2024	2025
Net sales	10.97B 2.14B 1.86B 1.72B 1.61B 3.03B 201B 3.05B 20.46B 7.93B 99.17B 8.02B 7.84B 344B	12.48B 2.43B 2.12B 1.96B 1.84B 3.44B 229B 3.46B 23.26B 9.01B 113B 9.11B 8.92B 392B
Net income	117M 22.82M 19.9M 18.43M 17.25M 32.36M 2.15B 32.55M 219M 84.74M 1.06B 85.67M 83.83M 3.68B	571M 111M 96.96M 89.8M 84.06M 158M 10.49B 159M 1.07B 413M 5.16B 417M 408M 17.93B
Net Debt	-	-

* Estimated data More financial data

Company Profile

Employees

13,000

Sector

More about the company

Income Statement and Estimates

More financial data